Crown Bioscience’s Post

Our latest poster from AACR24 introduces SynAI, a state-of-the-art AI-driven solution poised to redefine the approach to predicting drug synergism in cancer cell lines. By harnessing the power of compound SMILE sequences, SynAI offers a swift, efficient, and cost-effective method for identifying promising therapeutic combinations. Download this poster to discover: ✅SynAI's unmatched flexibility and efficiency in drug synergy prediction. ✅The AI core's sophisticated methodology, trained on comprehensive cancer cell line datasets. ✅SynAI's evolutionary potential to refine cancer treatment discovery with ongoing data integration. ➡️ https://hubs.la/Q02JdyRQ0 #AI #DrugSynergy

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/dkzRC9bx #biomarkers #oncology #ParexelBiotech #NovelInsights

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/ekhwfXqJ #biomarkers #oncology #ParexelBiotech #NovelInsights

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. 🔎 At Parexel, our team of experts is leveraging diverse data streams and exciting advances in #AI and #machinelearning to fast-track cancer research and improve patient outcomes. We asked Angela Qu to describe how recent advances in multi-omics and computational analytics accelerate the discovery and validation of biomarkers in precision oncology. Read her responses at the link below! #Biomarkers #Oncology #PrecisionOncology #NovelInsights

We're thrilled to announce our latest feature: Model Relationships! At CancerModels.Org, we're constantly striving to enhance the user experience and provide invaluable tools for researchers, clinicians, and bioinformaticians in the field of cancer research and drug development. With the introduction of Model Relationships, navigating the complex relationships between patient-derived cancer models has never been easier. Model relationships are visualized in a hierarchy tree, showing the intricate connections between different cancer models, illustrating how one model may be derived from others, and vice versa. Here's a great example of a Model Relationship tree: https://lnkd.in/ekVkaeGg As always, we value your input and strive to improve CancerModels.org based on your needs and suggestions. We invite you to explore the Model Relationships and share your feedback with us. Together, we can continue to advance cancer research and drug development for the benefit of patients worldwide. #CancerResearch #DrugDevelopment #PatientDerivedModels #CancerModelsOrg #ResearchTools #Innovation #Science #DataVisualization

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/gA4sTGG8 #biomarkers #oncology #ParexelBiotech #NovelInsights

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/gW2rfExF #biomarkers #oncology #ParexelBiotech #NovelInsights

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/dzZgs7Kw #biomarkers #oncology #ParexelBiotech #NovelInsights

AI focus - how times have changed into exciting times indeed. Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/eyKTaFi9, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data #biomarkers #oncology #NovelInsights

Are biomarkers the key to diagnosing and treating cancer effectively? 🔑 They help identify patients who will benefit most from targeted therapies, making clinical trials faster and more efficient. However, reliable biomarkers are still lacking for many cancers. At Parexel, we are using advanced -omics tools and deep learning to discover and validate biomarkers in precision oncology. 🔎 Our team of experts is leveraging diverse data streams and exciting advances in AI and machine learning to fast-track cancer research and improving patient outcomes. Hear more from Dr. Angela Qu: https://lnkd.in/efUVVhQ9 #biomarkers #oncology #ParexelBiotech #NovelInsights